A detailed history of Capital Advisors, Ltd. LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 106 shares of EBS stock, worth $879. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106
Previous 30 253.33%
Holding current value
$879
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$5.72 - $14.77 $434 - $1,122
76 Added 253.33%
106 $1,000
Q2 2024

Jul 25, 2024

SELL
$1.86 - $6.98 $3,667 - $13,764
-1,972 Reduced 98.5%
30 $0
Q1 2024

Apr 18, 2024

BUY
$1.5 - $3.41 $3,003 - $6,826
2,002 New
2,002 $5,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $414M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.